Business Context and Reporting Period
This Form 8-K is filed by Anthem, Inc. (now Elevance Health, Inc.) on January 31, 2018, reporting events occurring on January 30, 2018. The filing primarily serves to announce the election of a new independent director and to incorporate by reference the press release detailing financial results for the fourth quarter and full year ended December 31, 2017.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes and Corporate Governance
- Board Election: On January 30, 2018, the Board of Directors elected Bahija Jallal as an independent director, effective February 1, 2018.
- Committee Assignments: Ms. Jallal was appointed to the Compensation and Governance Committees.
- Term: Her term expires at the 2019 annual meeting of shareholders.
- Compensation: Ms. Jallal will be compensated in accordance with the standard program for non-employee directors.
Guidance, Risks, and Contingencies
The filing includes a comprehensive list of forward-looking statements and associated risks. Key areas of uncertainty include:
- Regulatory Environment: Ongoing changes to the Affordable Care Act (ACA) and regulations regarding Medicare and Medicaid programs.
- Operational Risks: Trends in healthcare costs, provider contracting, premium rate approvals, and enrollment levels.
- Legal and Litigation: Significant risks related to litigation with Cigna Corporation regarding their failed merger agreement, including potential termination fees and damages.
- Financial Risks: Substantial outstanding indebtedness, potential downgrades in financial strength ratings, and impairment of intangible assets.
- External Factors: Cybersecurity threats, public health epidemics, and general economic downturns.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2017 financial figures, as they are not listed in the 8-K text.
- Monitor the status of the litigation with Cigna Corporation regarding the merger termination fee and damages.
- Assess the impact of regulatory changes to the ACA and CMS Star ratings on future revenue streams.
- Verify the company's liquidity position and debt levels given the disclosed risk of substantial indebtedness.